As of April 28, 2025, Accolade (ACCD) has a market cap of $0.58 billion USD. According to our data, Accolade is ranked No.5852 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 28, 2025 | $0.58 B |
106.05%
|
Dec 31, 2024 | $0.28 B |
-71.52%
|
Dec 29, 2023 | $0.98 B |
54.17%
|
Dec 30, 2022 | $0.64 B |
-70.45%
|
Dec 31, 2021 | $2.15 B |
-39.40%
|
Dec 31, 2020 | $3.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Teladoc Health
TDOC
|
$1.27 B |
10.454 M
|
![]() USA
|
![]() Health Catalyst
HCAT
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Allscripts
MDRX
|
$0.45 B |
-0.000 M
|
![]() USA
|
![]() Evolent Health
EVH
|
$1.10 B |
13.323 M
|
![]() USA
|
![]() Phreesia
PHR
|
$1.44 B |
0.000 M
|
![]() USA
|
![]() Veeva Systems
VEEV
|
$36.76 B |
27.544 M
|
![]() USA
|
![]() Omnicell
OMCL
|
$1.46 B |
11.667 M
|
![]() USA
|
Market Cap | = | ACCD Stock Price | * | ACCD Shares Outstanding |
= | $7.02 | * | 81.99 M | |
= | $0.58 B |